Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Moreau

Showing results (161-170 of 787) with videos related to

Pageof 79
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 27, 2021
Reaction Mechanisms of the Degradation of Fluoroethylene Carbonate, an Additive of Lithium-Ion Batteries, Unraveled by Radiation ChemistryMarin Puget, Viacheslav Shcherbakov, Sergey Denisov, et al.
Advances in Immunology|January 9, 2004
HLA-G molecules: from maternal-fetal tolerance to tissue acceptanceEdgardo D Carosella, Philippe Moreau, Joël Le Maoult, et al.
Pharmacological Research|November 26, 2016
Deacetylase inhibitors as a novel modality in the treatment of multiple myelomaPaul G Richardson, Philippe Moreau, Jacob P Laubach, et al.
Cytotherapy|June 5, 2013
Characterization of peripheral blood stem cell grafts mobilized by granulocyte colony-stimulating factor and plerixafor compared with granulocyte colony-stimulating factor aloneBeatrice Gaugler, Jessy Arbez, Steven Legouill, et al.
American Journal of Hematology|May 31, 2021
Covid-19 vaccination in patients with multiple myeloma: Focus on immune responseHeinz Ludwig, Jesús San-Miguel, Nikhil Munshi, et al.
Spine|July 9, 2016
Overall Survival in Spine Myeloma Metastases: Difficulties in Predicting With Prognostic ScoresAymeric Amelot, Joseph Cristini, Céline Salaud, et al.
International Journal of Antimicrobial Agents|January 18, 2006
Trough serum concentrations of beta-lactam antibiotics in cancer patients: inappropriateness of conventional schedules to pharmacokinetic/pharmacodynamic properties of beta-lactamsDominique Navas, Jocelyne Caillon, Eric Batard, et al.
Future Oncology (London, England)|December 14, 2019
Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study designPhilippe Moreau, Meletios A Dimopoulos, Kwee Yong, et al.
Leukemia & Lymphoma|April 4, 2019
The challenge of myeloma-related thromboembolic disease: can thrombin generation assay help physicians to better predict the thromboembolic risk and personalize anti-thrombotic prophylaxis?Yesim Dargaud, Marc Fouassier, Jean Claude Bordet, et al.
ACS Applied Materials & Interfaces|September 12, 2022
Pristine Surface of Ni-Rich Layered Transition Metal Oxides as a Premise of Surface ReactivityAngelica Laurita, Liang Zhu, Pierre-Etienne Cabelguen, et al.
Pageof 79

Showing results (161-170 of 787) with videos related to

Sort By:
Pageof 79
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 27, 2021
Reaction Mechanisms of the Degradation of Fluoroethylene Carbonate, an Additive of Lithium-Ion Batteries, Unraveled by Radiation ChemistryMarin Puget, Viacheslav Shcherbakov, Sergey Denisov, et al.
Advances in Immunology|January 9, 2004
HLA-G molecules: from maternal-fetal tolerance to tissue acceptanceEdgardo D Carosella, Philippe Moreau, Joël Le Maoult, et al.
Pharmacological Research|November 26, 2016
Deacetylase inhibitors as a novel modality in the treatment of multiple myelomaPaul G Richardson, Philippe Moreau, Jacob P Laubach, et al.
Cytotherapy|June 5, 2013
Characterization of peripheral blood stem cell grafts mobilized by granulocyte colony-stimulating factor and plerixafor compared with granulocyte colony-stimulating factor aloneBeatrice Gaugler, Jessy Arbez, Steven Legouill, et al.
American Journal of Hematology|May 31, 2021
Covid-19 vaccination in patients with multiple myeloma: Focus on immune responseHeinz Ludwig, Jesús San-Miguel, Nikhil Munshi, et al.
Spine|July 9, 2016
Overall Survival in Spine Myeloma Metastases: Difficulties in Predicting With Prognostic ScoresAymeric Amelot, Joseph Cristini, Céline Salaud, et al.
International Journal of Antimicrobial Agents|January 18, 2006
Trough serum concentrations of beta-lactam antibiotics in cancer patients: inappropriateness of conventional schedules to pharmacokinetic/pharmacodynamic properties of beta-lactamsDominique Navas, Jocelyne Caillon, Eric Batard, et al.
Future Oncology (London, England)|December 14, 2019
Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study designPhilippe Moreau, Meletios A Dimopoulos, Kwee Yong, et al.
Leukemia & Lymphoma|April 4, 2019
The challenge of myeloma-related thromboembolic disease: can thrombin generation assay help physicians to better predict the thromboembolic risk and personalize anti-thrombotic prophylaxis?Yesim Dargaud, Marc Fouassier, Jean Claude Bordet, et al.
ACS Applied Materials & Interfaces|September 12, 2022
Pristine Surface of Ni-Rich Layered Transition Metal Oxides as a Premise of Surface ReactivityAngelica Laurita, Liang Zhu, Pierre-Etienne Cabelguen, et al.
Pageof 79